Development of a castrate resistant transplant tumor model of prostate cancer.

作者: Leigh Ellis , Kristin Lehet , Swathi Ramakrishnan , Remi Adelaiye , Roberto Pili

DOI: 10.1002/PROS.21465

关键词:

摘要: BACKGROUND Currently, limited mouse models that mimic the clinical course of castrate resistant prostate development currently exist. Such are urgently required to conduct pre-clinical studies assist in understanding disease progression and rational therapeutic strategies treat cancer. METHODS Wild type intact FVB male mice were injected by subcutaneous injection with Myc-CaP cells establish androgen sensitive tumors. Tumor bearing castrated resulting tumors serially passaged pre-castrated produce a bone fide tumor. RESULTS Immunohistochemical analysis revealed initial had strong nuclear transcriptional active receptor expression, as indicated marked c-MYC staining highly proliferative. Castration tumor animals resulted cytoplasmic relocation concurrent loss activity proliferation. Serial passaging refractory bona which pheno-copied original parental tumor. CONCLUSIONS Developing murine transplant model mimics human cancer will create better opportunities understand also allow for more rapid stratify novel therapies this lethal form cancer. Prostate 72:587–591, 2012. © 2011 Wiley Periodicals, Inc.

参考文章(11)
Kenneth J. Pienta, Cory Abate-Shen, David B. Agus, Ricardo M. Attar, Leland W.K. Chung, Norman M. Greenberg, William C. Hahn, John T. Isaacs, Nora M. Navone, Donna M. Peehl, Jonathon W. Simons, David B. Solit, Howard R. Soule, Terry A. VanDyke, Michael J. Weber, Lily Wu, Robert L. Vessella, The current state of preclinical prostate cancer animal models. The Prostate. ,vol. 68, pp. 629- 639 ,(2008) , 10.1002/PROS.20726
Leigh Ellis, Michael Bots, Ralph K. Lindemann, Jessica E. Bolden, Andrea Newbold, Leonie A. Cluse, Clare L. Scott, Andreas Strasser, Peter Atadja, Scott W. Lowe, Ricky W. Johnstone, The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy Blood. ,vol. 114, pp. 380- 393 ,(2009) , 10.1182/BLOOD-2008-10-182758
Chun-Peng Liao, Mengmeng Liang, Michael B. Cohen, Andrea Flesken-Nikitin, Joseph H. Jeong, Alexander Y. Nikitin, Pradip Roy-Burman, Mouse prostate cancer cell lines established from primary and postcastration recurrent tumors. Hormones and Cancer. ,vol. 1, pp. 44- 54 ,(2010) , 10.1007/S12672-009-0005-Y
Charlie D Chen, Derek S Welsbie, Chris Tran, Sung Hee Baek, Randy Chen, Robert Vessella, Michael G Rosenfeld, Charles L Sawyers, Molecular determinants of resistance to antiandrogen therapy Nature Medicine. ,vol. 10, pp. 33- 39 ,(2004) , 10.1038/NM972
Shunyou Wang, Jing Gao, Qunying Lei, Nora Rozengurt, Colin Pritchard, Jing Jiao, George V. Thomas, Gang Li, Pradip Roy-Burman, Peter S. Nelson, Xin Liu, Hong Wu, Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer Cancer Cell. ,vol. 4, pp. 209- 221 ,(2003) , 10.1016/S1535-6108(03)00215-0
R. K. Lindemann, A. Newbold, K. F. Whitecross, L. A. Cluse, A. J. Frew, L. Ellis, S. Williams, A. P. Wiegmans, A. E. Dear, C. L. Scott, M. Pellegrini, A. Wei, V. M. Richon, P. A. Marks, S. W. Lowe, M. J. Smyth, R. W. Johnstone, Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 8071- 8076 ,(2007) , 10.1073/PNAS.0702294104
Howard I. Scher, Charles L. Sawyers, Biology of Progressive, Castration-Resistant Prostate Cancer: Directed Therapies Targeting the Androgen-Receptor Signaling Axis Journal of Clinical Oncology. ,vol. 23, pp. 8253- 8261 ,(2005) , 10.1200/JCO.2005.03.4777
C. Tran, S. Ouk, N. J. Clegg, Y. Chen, P. A. Watson, V. Arora, J. Wongvipat, P. M. Smith-Jones, D. Yoo, A. Kwon, T. Wasielewska, D. Welsbie, C. D. Chen, C. S. Higano, T. M. Beer, D. T. Hung, H. I. Scher, M. E. Jung, C. L. Sawyers, Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer Science. ,vol. 324, pp. 787- 790 ,(2009) , 10.1126/SCIENCE.1168175
Philip A. Watson, Katharine Ellwood-Yen, Jennifer C. King, John Wongvipat, Michelle M. LeBeau, Charles L. Sawyers, Context-Dependent Hormone-Refractory Progression Revealed through Characterization of a Novel Murine Prostate Cancer Cell Line Cancer Research. ,vol. 65, pp. 11565- 11571 ,(2005) , 10.1158/0008-5472.CAN-05-3441
Jing Jiao, Shunyou Wang, Rong Qiao, Igor Vivanco, Philip A. Watson, Charles L. Sawyers, Hong Wu, Murine Cell Lines Derived from Pten Null Prostate Cancer Show the Critical Role of PTEN in Hormone Refractory Prostate Cancer Development Cancer Research. ,vol. 67, pp. 6083- 6091 ,(2007) , 10.1158/0008-5472.CAN-06-4202